Irinotecan plus temozolomide in relapsed Ewing sarcoma: an integrated analysis of retrospective studies
oleh: Bi-Cheng Wang, Bo-Ya Xiao, Guo-He Lin
| Format: | Article |
|---|---|
| Diterbitkan: | BMC 2022-03-01 |
Deskripsi
Highlights 1. Nearly 44% of relapsed Ewing sarcoma patients achieved an ORR after IT treatment. 2. Relapsed Ewing sarcoma treated with IT had an over 66% DCR. 3. IT chemotherapy caused low incidences of neutropenia, thrombocytopenia, and diarrhea in treating relapsed Ewing sarcoma.